Mr. Sharpe has over 30 years experience in the life sciences industry in marketing, sales, and operations in medical devices, medical imaging, diagnostics, and pharmaceuticals. Mr. Sharpe has been CEO of a public biotech company, President of a drug discovery company, and COO of a drug delivery company. He has raised over $20 million for start-ups and early stage companies, and has an extensive background in business development including M&A.

Dr. Siegel has held research management roles at Hoffmann-LaRoche, and a business development role at Lederle-Praxis, where he worked directly with the CEO in the sale of the company to Lederle Laboratories. Subsequent to Praxis, he worked in an investment banking role working with emerging biomedical companies. He was also a Director in an Ohio economic development organization where he was instrumental in starting five companies.

Founder of Point Source, Inc., which designs, develops and manufactures optical and electronic imaging systems and instrumentation for the medical field. Prior to Point Source Mr. Mersch was a Senior Scientist at Ethicon Endo-Surgery where he was a project leader in the development of surgical tools for minimally invasive surgery. Prior to Ethicon, Mr. Mersch was a Research Physicist at Becton Dickinson. Mr. Mersch has 30 issued patents.

Dr. Crane is retired from the U.S. Air Force, where he was a Fellow of the Air Force Institute of Technology. He is the lead inventor of INRIS’s infrared imaging technology. His specialties include materials science, optics and physics. He is an Adjunct Professor at The Air Force Institute of Technology, Wright State University, University of Dayton and University of California at Los Angeles. He is the inventor of 5 commercial technologies.

Mr. Schlesinger has extensive experience in investment banking in large NYC firms, mostly in public and private offerings, advisory services and M&A. He has co-founded a venture capital fund and a financial services firm and has raised capital for and invested in several venture stage companies. He has been involved with companies in medical devices, specialized healthcare services and generic pharmaceuticals. AB and an MBA from Harvard.